MiMedx Group, Inc.MDXGNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+5.9%
5Y CAGR+5.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+5.9%/yr
vs -5.3%/yr prior
5Y CAGR
+5.2%/yr
Consistent
Acceleration
+11.2pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$15.10M+22.3%
2024$12.34M-2.6%
2023$12.66M-0.3%
2022$12.70M+27.9%
2021$9.93M-15.2%
2020$11.71M+5.2%
2019$11.14M-29.3%
2018$15.77M-11.9%
2017$17.90M+24.8%
2016$14.34M-